Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004.

[1]  Pam Tucker,et al.  Toxicological Profile for Cadmium , 2012 .

[2]  A. Holmgren,et al.  Biomarkers of Adverse Response to Mercury: Histopathology versus Thioredoxin Reductase Activity , 2012, Journal of biomedicine & biotechnology.

[3]  A. Holmgren,et al.  Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. , 2012, Free radical biology & medicine.

[4]  A. Al-Attar.  Vitamin E attenuates liver injury induced by exposure to lead, mercury, cadmium and copper in albino mice. , 2011, Saudi journal of biological sciences.

[5]  H. Inui,et al.  Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3',4,4',5-pentachlorobiphenyl. , 2011, Journal of biochemistry.

[6]  Chaofeng Shen,et al.  PCB congeners induced mitochondrial dysfunction in Vero cells. , 2011, Journal of hazardous materials.

[7]  D. Carpenter,et al.  Blood Pressure in Relation to Concentrations of PCB Congeners and Chlorinated Pesticides , 2010, Environmental health perspectives.

[8]  Guy Brock,et al.  Polychlorinated Biphenyls, Lead, and Mercury Are Associated with Liver Disease in American Adults: NHANES 2003–2004 , 2010, Environmental health perspectives.

[9]  S. Bhattacharya,et al.  Induction of oxidative stress by non-lethal dose of mercury in rat liver: possible relationships between apoptosis and necrosis. , 2010, Journal of environmental biology.

[10]  Chris Gennings,et al.  Identifying Subsets of Complex Mixtures Most Associated With Complex Diseases: Polychlorinated Biphenyls and Endometriosis as a Case Study , 2010, Epidemiology.

[11]  H. Inui,et al.  Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. , 2009, The Journal of nutrition.

[12]  F. Al-Mohanna,et al.  Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS‐55 , 2009, Obesity.

[13]  W. Lukiw,et al.  Mercury from chlor-alkali plants: measured concentrations in food product sugar , 2009, Environmental health : a global access science source.

[14]  Andreas Kortenkamp,et al.  Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. , 2008, International journal of andrology.

[15]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[16]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[17]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[18]  J. Thornton,et al.  Biomonitoring of Industrial Pollutants: Health and Policy Implications of the Chemical Body Burden , 2002, Public health reports.

[19]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[20]  A. Schecter,et al.  Intake Of Dioxins and Related Compounds from Food in the U.S. Population , 2001, Journal of toxicology and environmental health. Part A.

[21]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[22]  O. Faroon,et al.  Toxicological profile for polychlorinated biphenyls (PCBs) , 2000 .

[23]  H. Cortez‐Pinto,et al.  Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.

[24]  K. Reuhl,et al.  Toxicological profile for mercury , 1999 .

[25]  D. Camann,et al.  Proposed PCB congener groupings for epidemiological studies. , 1997, Environmental health perspectives.

[26]  V. Cogliano,et al.  PUBLIC HEALTH IMPLICATIONS OF EXPOSURE TO POLYCHLORINATED BIPHENYLS (PCBs) , 2001 .

[27]  H. Scoville.  The Limitation of Offensive Weapons , 1971 .